These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31169350)

  • 1. Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.
    Sobieraj P; Lewandowski J; Siński M; Gaciong Z
    J Clin Hypertens (Greenwich); 2019 Jul; 21(7):911-918. PubMed ID: 31169350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the optimal on-treatment diastolic blood pressure range using automated office measurements in patients without cardiovascular disease.
    Sobieraj P; Lewandowski J; Siński M
    Pol Arch Intern Med; 2021 Mar; 131(3):249-256. PubMed ID: 33511815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT.
    Sobieraj P; Lewandowski J; Siński M; Symonides B; Gaciong Z
    J Am Heart Assoc; 2019 Feb; 8(4):e010811. PubMed ID: 30744452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
    Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
    Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
    Kario K; Iwashita M; Okuda Y; Sugiyama M; Saito I; Kushiro T; Teramukai S; Shimada K
    Hypertension; 2018 Oct; 72(4):854-861. PubMed ID: 30354719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Risk in Hypertension in Relation to Achieved Blood Pressure Using Automated Office Blood Pressure Measurement.
    Myers MG; Kaczorowski J; Dolovich L; Tu K; Paterson JM
    Hypertension; 2016 Oct; 68(4):866-72. PubMed ID: 27528062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.
    Itoga NK; Tawfik DS; Lee CK; Maruyama S; Leeper NJ; Chang TI
    Circulation; 2018 Oct; 138(17):1805-1814. PubMed ID: 29930023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalizability of SPRINT Results to the U.S. Adult Population.
    Bress AP; Tanner RM; Hess R; Colantonio LD; Shimbo D; Muntner P
    J Am Coll Cardiol; 2016 Feb; 67(5):463-72. PubMed ID: 26562046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease.
    Chang TI; Wei G; Boucher R; Kramer H; Chertow GM; Cheung AK; Greene T; Whelton PK; Beddhu S
    Kidney360; 2020 May; 1(5):368-375. PubMed ID: 35369376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
    Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
    JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure targets in adults with hypertension.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
    Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
    Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
    Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
    JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial).
    Chang TI; Reboussin DM; Chertow GM; Cheung AK; Cushman WC; Kostis WJ; Parati G; Raj D; Riessen E; Shapiro B; Stergiou GS; Townsend RR; Tsioufis K; Whelton PK; Whittle J; Wright JT; Papademetriou V;
    Hypertension; 2017 Oct; 70(4):751-758. PubMed ID: 28760939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.